Who is Responsible for Cancer Survivorship Care?

Article

As the needs of cancer survivors have been determined and researched, there is still confusion about which medical professional cares for what part of their survival.

Through research the needs of cancer survivors have been identified, but questions about who and how survivors will be followed remains.

Anna Meadows, M.D., professor Emeritus at the Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, addressed the issue of avoidance in her morning presentation at the Cancer Survivorship Symposium: Advancing Care and Research.

She has found that few childhood survivors or their parents want to be reminded of their cancer experience by going in for checkups or filling out surveys. The medical community sees many follow up areas that can easily be followed by primary care physicians (PCP), many of whom understand they are the logical provider, while reminding the cancer community that their training didn't include the specifics of caring for cancer survivors.

Who is the best person to provide patient centered care? This was a question that this morning’s research showed is confusing for not only survivors, but also oncologists, survivor care specialists affiliated with cancer centers and PCPs.

Researchers presenting from the University of Michigan at Ann Arbor based their discussion on a statement from the 2013 IOM report Delivering High Quality Cancer Care, which called for coordinated care among the cancer care team, primary care providers and geriatric providers. The researchers accrued 5,200 women cancer survivors and asked them a number of questions about who they would prefer to follow them in a number of areas. The results showed a number of challenges for this team-based approach — primarily that most women want their oncologist to follow them for cancer related issues and their PCPs to follow them for other health concerns.

There could be many reasons for this, including not wanting to replace the relationships forged while going through cancer. Trust is a hard thing to replace, particularly when fear of recurrence follows you for years. And, while many of the follow up specifics are clearly areas that can be monitored by PCPs, many see themselves as unprepared.

Between speakers I struck up a conversation with the young woman sitting next to me. She is a PCP who has recently had a number of cancer survivors added to her practice. As we talked briefly she said her attendance at the meeting was to learn as much as possible about what her survivor patients need since she knew very little about their concerns. I recommended she subscibe to CURE and Heal to help with her education.

The sessions that followed looked at designs for PCP education, as well as outreach to patients including community based clinics, designs for primary care physicians, telemedicine and even a renovated 18-wheeler that covers rural communities in northeast Texas.

No matter who is assigned the tasks of following survivors, you have to remember to ask: If we build it, will they come?

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content